FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1998810366> ?p ?o ?g. }

• W1998810366 endingPage "1014" @default.
• W1998810366 startingPage "1009" @default.
• W1998810366 abstract "The genes responsible for insulin resistance are also candidate genes for insulin resistance-related diseases, such as obesity and hypertension. Functional polymorphisms in the β2- and β3-adrenergic receptors have been reported to be associated with diabetes, hypertension, and obesity. To clarify the relevance of the β-adrenergic receptor polymorphisms to insulin resistance, we studied their association with polymorphisms of β2 (Arg16Gly, Gln27Glu) and β3 (Trp64Arg) adrenoceptor genes. We studied 155 young, nonobese Japanese men using the homeostasis model assessment of insulin resistance (HOMA-IR) to divide individuals into insulin-sensitive and insulin-resistant groups. Insulin resistance in the participants was defined as HOMA-IR equal to or greater than the average plus 1 SD of 3.1. There were 69 men who were insulin resistant and 86 men who were insulin sensitive. Body mass index (BMI), blood pressure (BP), plasma glucose, insulin, leptin, norepinephrine (NE) levels, and the polymorphisms of Arg16Gly and Gln27Glu of the β2- and Trp64Arg of the β3-adrenoceptor polymorphisms were measured in all participants. The insulin-resistant group had higher frequency of the Gly16 allele of Arg16Gly compared with the insulin-sensitive group, whereas the frequencies of genotypes or alleles of Gln27Glu and Trp64Arg were similar. The insulin-resistant group had a higher mean HOMA-IR, fasting insulin, NE, and total fat mass compared with levels in the insulin-sensitive group, but the BMI and leptin levels were similar. The subjects carrying the Gly16 allele of the β2-adrenoceptor gene had a higher mean HOMA-IR, fasting insulin, NE, body fat mass, and BP than those without the Gly16 allele. The Gly16 mutation of the β2-adrenoceptor gene is associated with increased insulin resistance, adiposity, and BP accompanied by higher plasma NE levels early in the metabolic disease in developing obesity. These findings show an important role of β2-adrenoceptor gene polymorphisms in the association of insulin resistance in hypertension and obesity. Am J Hypertens 2005;18:1009–1014 © 2005 American Journal of Hypertension, Ltd." @default.
• W1998810366 created "2016-06-24" @default.
• W1998810366 creator A5016219128 @default.
• W1998810366 creator A5021267745 @default.
• W1998810366 creator A5067833626 @default.
• W1998810366 creator A5069785747 @default.
• W1998810366 creator A5078822609 @default.
• W1998810366 creator A5078824728 @default.
• W1998810366 date "2005-07-01" @default.
• W1998810366 modified "2023-10-16" @default.
• W1998810366 title "β-Adrenoceptor Polymorphisms Relate to Insulin Resistance and Sympathetic Overactivity as Early Markers of Metabolic Disease in Nonobese, Normotensive Individuals" @default.
• W1998810366 cites W17021510 @default.
• W1998810366 cites W1862838614 @default.
• W1998810366 cites W1967944474 @default.
• W1998810366 cites W1971901096 @default.
• W1998810366 cites W1973327917 @default.
• W1998810366 cites W1985908429 @default.
• W1998810366 cites W1989970148 @default.
• W1998810366 cites W2004649944 @default.
• W1998810366 cites W2019749867 @default.
• W1998810366 cites W2029727332 @default.
• W1998810366 cites W2030765035 @default.
• W1998810366 cites W2052935499 @default.
• W1998810366 cites W2053454761 @default.
• W1998810366 cites W2075349145 @default.
• W1998810366 cites W2077168170 @default.
• W1998810366 cites W2091732895 @default.
• W1998810366 cites W2100129473 @default.
• W1998810366 cites W2107144085 @default.
• W1998810366 cites W2118825573 @default.
• W1998810366 cites W2120521590 @default.
• W1998810366 cites W2140350955 @default.
• W1998810366 cites W2149376469 @default.
• W1998810366 cites W2154485751 @default.
• W1998810366 cites W2160859079 @default.
• W1998810366 cites W2322463216 @default.
• W1998810366 cites W2328516579 @default.
• W1998810366 cites W2336925169 @default.
• W1998810366 cites W2425327377 @default.
• W1998810366 cites W6339482 @default.
• W1998810366 doi "https://doi.org/10.1016/j.amjhyper.2005.01.006" @default.
• W1998810366 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16054001" @default.
• W1998810366 hasPublicationYear "2005" @default.
• W1998810366 type Work @default.
• W1998810366 sameAs 1998810366 @default.
• W1998810366 citedByCount "54" @default.
• W1998810366 countsByYear W19988103662012 @default.
• W1998810366 countsByYear W19988103662013 @default.
• W1998810366 countsByYear W19988103662014 @default.
• W1998810366 countsByYear W19988103662015 @default.
• W1998810366 countsByYear W19988103662016 @default.
• W1998810366 countsByYear W19988103662017 @default.
• W1998810366 countsByYear W19988103662018 @default.
• W1998810366 countsByYear W19988103662019 @default.
• W1998810366 countsByYear W19988103662020 @default.
• W1998810366 countsByYear W19988103662021 @default.
• W1998810366 countsByYear W19988103662022 @default.
• W1998810366 countsByYear W19988103662023 @default.
• W1998810366 crossrefType "journal-article" @default.
• W1998810366 hasAuthorship W1998810366A5016219128 @default.
• W1998810366 hasAuthorship W1998810366A5021267745 @default.
• W1998810366 hasAuthorship W1998810366A5067833626 @default.
• W1998810366 hasAuthorship W1998810366A5069785747 @default.
• W1998810366 hasAuthorship W1998810366A5078822609 @default.
• W1998810366 hasAuthorship W1998810366A5078824728 @default.
• W1998810366 hasBestOaLocation W19988103661 @default.
• W1998810366 hasConcept C104317684 @default.
• W1998810366 hasConcept C112446052 @default.
• W1998810366 hasConcept C126322002 @default.
• W1998810366 hasConcept C134018914 @default.
• W1998810366 hasConcept C180754005 @default.
• W1998810366 hasConcept C2777391703 @default.
• W1998810366 hasConcept C2779306644 @default.
• W1998810366 hasConcept C2780221984 @default.
• W1998810366 hasConcept C2780613262 @default.
• W1998810366 hasConcept C511355011 @default.
• W1998810366 hasConcept C54355233 @default.
• W1998810366 hasConcept C555293320 @default.
• W1998810366 hasConcept C71924100 @default.
• W1998810366 hasConcept C84393581 @default.
• W1998810366 hasConcept C86803240 @default.
• W1998810366 hasConceptScore W1998810366C104317684 @default.
• W1998810366 hasConceptScore W1998810366C112446052 @default.
• W1998810366 hasConceptScore W1998810366C126322002 @default.
• W1998810366 hasConceptScore W1998810366C134018914 @default.
• W1998810366 hasConceptScore W1998810366C180754005 @default.
• W1998810366 hasConceptScore W1998810366C2777391703 @default.
• W1998810366 hasConceptScore W1998810366C2779306644 @default.
• W1998810366 hasConceptScore W1998810366C2780221984 @default.
• W1998810366 hasConceptScore W1998810366C2780613262 @default.
• W1998810366 hasConceptScore W1998810366C511355011 @default.
• W1998810366 hasConceptScore W1998810366C54355233 @default.
• W1998810366 hasConceptScore W1998810366C555293320 @default.
• W1998810366 hasConceptScore W1998810366C71924100 @default.
• W1998810366 hasConceptScore W1998810366C84393581 @default.
• W1998810366 hasConceptScore W1998810366C86803240 @default.
• W1998810366 hasIssue "7" @default.
• W1998810366 hasLocation W19988103661 @default.

• next